RANDOMISED CONTROLLED TRIAL OF INTRAMUSCULAR PENTAZOCINE VERSUS INTRAMUSCULAR DICLOFENAC FOR PAIN RELIEF DURING MANUAL VACUUM ASPIRATION AT FEDERAL TEACHING HOSPITAL KATSINA.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202212482289582

Enrollment

100

Registered

2022-12-19

Start date

2020-08-10

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAIN RELIEF DURING MANUAL VACUUM ASPIRATION

Interventions

INTRAMUSCULAR PENTAZOCINE

INTRAMUSCULAR DICLOFENAC

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ALL CONSENTING WOMEN WHO PRESENTED WITH A MISCARRIAGE OF LESS THAN 12 WEEKS FOR MANUAL VACUUM ASPIRATION

Exclusion criteria

Exclusion criteria: MVA FOR ANY OTHER INDICATION APART FROM MISCARRIAGE. OBESITY WOMEN IN WHOM DICLOFENAC IS CONTRAINDICATED LIKE THOSE WITH PEPTIC ULCER DISEASE. HISTORY OF HYPERSENSITIVITY TO PENTAZOCINE OR DICLOFENAC. USE OF ANY KIND OF ANALGESIA WITHIN 12 HOURS. UNCONSCIOUS PATIENTS. PATIENTS IN SHOCK REQUIRING RESUSCITATION.

Design outcomes

Primary

Measure	Time frame
PAIN PERCEPTION USING VISUAL ANALOGUE SCORE	—

Secondary

Measure	Time frame
PATIENT SATISFACTION USING LIKERT SCALE AND SIDE EFFECTS PROFILE	—

Countries

Nigeria

Contacts

Public ContactAISHA ABDURRHAMAN

CONSULTANT

aisha_abdurrahman@yahoo.com2348033096164

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026